Forbes Earnings Preview: GlaxoSmithKline

Analysts have become increasingly bearish on GlaxoSmithKline (GSK) in the month leading up to the company's first quarter earnings announcement scheduled for Wednesday, April 24, 2013. The consensus analyst estimate has moved from 85 cents a share to the current prediction of earnings of 77 cents a share.